C. Voss

Evaluation of Riproximin Binding Properties Reveals a Novel Mechanism for Cellular Targeting*

K. Essig, M. Berger, M. Frank, 2012, The Journal of Biological Chemistry.

Plant ribosome-inactivating proteins type II induce the unfolded protein response in human cancer cells

E. Flescher, M. Berger, Z. Raviv, 2011, Cellular and Molecular Life Sciences.

Identification of potent anticancer activity in Ximenia americana aqueous extracts used by African traditional medicine.

M. Berger, E. Eyol, C. Voss, 2006, Toxicology and applied pharmacology.

Identification and characterization of riproximin, a new type II ribosome‐inactivating protein with antineoplastic activity from Ximenia americana

M. Berger, M. Frank, C. Lieth, 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Purification and characterization of riproximin from Ximenia americana fruit kernels.

M. Berger, A. Wattenberg, H. Bayer, 2012, Protein expression and purification.

A novel, non-radioactive eukaryotic in vitro transcription assay for sensitive quantification of RNA polymerase II activity

J. Anderl, C. Voss, B. Schmitt, 2014, BMC Molecular Biology.

Lifelong exposure to di-(2-ethylhexyl)-phthalate induces tumors in liver and testes of Sprague-Dawley rats.

M. Berger, H. Zerban, P. Bannasch, 2005, Toxicology.

Evaluation of Riproximin Binding Properties Reveals a Novel Mechanism for Cellular Targeting*

K. Essig, M. Berger, M. Frank, 2012, The Journal of Biological Chemistry.